Fountainhead AM’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-142,143
Closed -$2.1M – 171
2025
Q3
$2.1M Buy
142,143
+53,787
+61% +$805K 0.28% 48
2025
Q2
$1.34M Buy
88,356
+31,823
+56% +$465K 0.19% 55
2025
Q1
$814K Buy
56,533
+3,322
+6% +$50.8K 0.13% 60
2024
Q4
$806K Sell
53,211
-359
-0.7% -$5.77K 0.15% 57
2024
Q3
$881K Buy
53,570
+1,095
+2% +$17.9K 0.19% 48
2024
Q2
$861K Buy
52,475
+4,905
+10% +$78.9K 0.2% 47
2024
Q1
$793K Buy
47,570
+921
+2% +$14.3K 0.19% 53
2023
Q4
$697K Buy
46,649
+13,766
+42% +$200K 0.19% 52
2023
Q3
$476K Buy
+32,883
New +$492K 0.17% 49

Other funds holding BCAT

Fountainhead AM's BCAT Position: Q4 2025 in Review

Fountainhead AM sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q4 2025, closing a stake of 142,143 shares — an estimated $2.1M sold.

Fountainhead AM first reported a position in BCAT in Q3 2023 and held it in 9 quarters. The position peaked at $2.1M in Q3 2025. 106 funds tracked by Wall St. Rank hold BCAT as of Q4 2025.

  • Fountainhead AM reported no remaining BlackRock Capital Allocation Term Trust position as of Q4 2025 after selling out during the quarter.
  • Fountainhead AM sold 142,143 BlackRock Capital Allocation Term Trust shares in Q4 2025, an estimated $2.1M.
  • Fountainhead AM first reported a position in BlackRock Capital Allocation Term Trust in Q3 2023 and held it in 9 quarters.
  • Fountainhead AM's BlackRock Capital Allocation Term Trust position peaked at $2.1M in Q3 2025.
  • 106 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q4 2025.

Based on Fountainhead AM's 13F filing for Q4 2025, filed 18 Feb 2026.